| Completed |
: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)
: - Hodgkin Disease
- Lymphoma, Large-Cell, Anaplastic
: 2016-10-18
: Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion.
|
| Completed |
: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
: ALCL
: 2016-09-07
: Other: Blood sample
|
| Active, not recruiting |
: A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
: - Lymphoma, Large-Cell, Anaplastic
- Lymphoma, NK-cell
: 2011-02-25
: - Drug: brentuximab vedotin 1.2-
|
| Completed |
: Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
: - Lymphoma, Non-Hodgkin
- HIV Infections
: 1999-11-02
: - Drug: Mitoxantrone hydrochloride
- Drug: Eto
|
| Completed |
: Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)
: - Lymphoma, B-Cell
- Lymphoma, Large-Cell, Immunoblastic
: 2006-05-22
: - Drug: Autologous transplantation using rituxan/BEAM
|
| Completed |
: Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
: - AIDS-related Diffuse Large Cell Lymphoma
- AIDS-related Immunoblastic La
: 2002-11-12
: - Biological: rituximab Given IV
|
| Completed |
: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
: - AIDS-related Non-Hodgkin Lymphoma
- AIDS-related Plasmablastic Lymphoma<
: 2013-09-09
:
|
| Completed |
: Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
: Lymphoma
: 1999-11-01
: - Biological: bleomycin sulfate
- Drug: CHOP r
|
| Not yet recruiting |
: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
: - Adult Burkitt Lymphoma
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D
: 2015-05-26
: - Drug: Cyclophosphamide Given I
|
| Active, not recruiting |
: Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
: - Accelerated Phase Chronic Myelogenous Leukemia
- Adult Acute Lymphoblastic Leukemia in Remissi
: 2004-08-04
: - Drug: fludarabine phosphate Gi
|
